Enter your terms above and click the 'Search' button.

Showing articles 0 to 8 of 8 Filter Applied: natalizumab (Click to remove) Monoclonal Antibody Therapies and Neurologic Disorders Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008 Natalizumab Treatment in a Patient With Chronic Inflammatory Demyelinating Polyneuropathy Arch Neurol 67:881-883, Wolf,C., et al, 2010 Maternal and Fetal Risks of Natalizumab Exposure in Utero Neurol 90:443-444, Marrie, R.A.,et al, 2018 Severe Relapses under Fingolimod Treatment Prescribed after Natalizumab Neurol 79:2004-2006,1942, Centonze, D.,et al, 2012 Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy Neurol 76:1697-1704, Vermersch,P.,et al, 2011 Management and Outcome of CSF-JC Virus PCR-negative PML in a Natalizumab-treated Patient with MS Neurol 77:2010-2016, Kuhle, J.,et al, 2011 Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study Arch Neurol 66:593-599, Boster,A.,et al, 2009 Progressive Multifocal Leukoencephalopathy Revisited: Has the Disease Outgrown Its Name? Ann Neurol 60:162-173, Koralnik,I.J., 2006 Showing articles 0 to 8 of 8